Western Haematology and Oncology Clinics is operated by Montserrat Cancer Care.
Our Specialists are experts in their field and are focused on providing their patients with the best care available including access to clinical trials.
Our centres facilitate a care philosophy of wellness through treatment for blood conditions and cancer, rather than illness.
Prof. Ross Baker
Professor Baker is currently:
- Director of Medical Services at Western Haematology and Oncology Clinics;
- Senior Consultant Haematologist at Hollywood Hospital;
- Director of the WA Centre for Thrombosis and Haemostasis at Murdoch University;
- Director of the Haemophilia Treatment Centre at Hollywood Hospital; and
- Chairman of Perth Blood Institute
Prof. Baker’s major interest is the translation of new scientific discoveries into clinical haematology practice. He has extensive clinical and laboratory experience in a wide range of haematological disorders and has been a consultant in haematology for over 20 years.
As Principal Investigator in more than 95 large international phase II and III clinical trials, he has actively led and participated in clinical research in venous thrombosis, leukaemia, lymphoma, myeloma, thrombocytopenia Von Willebrand disease and haemophilia. Since 1992 he has authored over 100 papers in peer reviewed journals and has been a regularly invited speaker at national and international haematology and medical meetings. He is a founding director and secretary of the Australasian Society for Thrombosis and Haemostasis (ASTH) and scientific advisor to the World Health Organisation on DVT in 2001.
He is also past President of the Australasian Society Thrombosis Haemostasis from 1997 to 2001, Haematology Advisory member of the Royal Australasian College of Pathologists 1998 to 2003 and Councillor for the Haematology Society of Australia and New Zealand from 1992 to 1999.
Professor Baker is currently an Australian Councillor on the Asian Pacific Thrombosis and Haemostasis Society (ASPTH) and Chairman of the Australasian Society of Thrombosis Haemostasis (ASTH) new oral anticoagulant Reversal and Event Collaborative (ARES), Asian Pacific Thrombosis and Thrombocytopenia Network (APTIN), the Perth Blood Institute and the executive committee for the International Society of Thrombosis and Haemostasis Meeting in Melbourne 2019.
Dr Maan Alwan
Dr Maan Alwan is a dual qualified clinical and laboratory haematologist. He completed his specialist training at Royal North Shore Hospital in Sydney. Dr Alwan has clinical interest in both malignant and non-malignant haematology. He is also strongly involved in clinical trials and research in myeloma, lymphoma and clotting and bleeding disorders as a clinical investigator at Perth Blood Institute.
Dr Alwan’s private consulting rooms are based at Western Haematology and Oncology Clinics in West Perth, and also provides consulting and clinical services at Hollywood Private Hospital (HPH) in Nedlands. Dr Alwan is a part-time laboratory haematologist at Western Diagnostic Pathology.
Dr Peter Tan
Dr Peter Tan is a haematologist specialising in haematological oncology, while also treating general haematological conditions including obstetric haematology, bleeding and clotting disorders. He consults at Western Haematology & Oncology Clinics and Royal Perth Hospital.
He understands that blood disorders are often complex and prioritises the provision of comprehensive and clear explanations. A new diagnosis may often cause a level of stress and uncertainty for patients and their families, therefore he plans to demystify the process of investigations and therapeutic options.
Dr Tan obtained his medical degree from the University of Western Australia (UWA) and commenced training at Royal Perth Hospital. Dr Tan completed his specialist training in haematology and bone marrow transplantation at St Vincent’s Hospital, Sydney. He obtained specialist qualifications in clinical and laboratory haematology from the RACP and RCPA.
Dr Tan held the position of the Kefford Leukaemia Research Fellow at the Alfred Hospital, Melbourne, for three years. Dr Tan performed clinical and translational research in blood cancers in conjunction with the Australian Centre for Blood Diseases (ACBD) and obtained a research degree at Monash University. He has published and presented early phase clinical trial findings in Acute Myeloid Leukaemia at international meetings. Dr Tan co-designed a national clinical trial conducted by the Australasian Leukaemia and Lymphoma Group (ALLG).
He is a principal investigator for clinical trials at the Perth Blood Institute (PBI) and at Royal Perth Hospital. He has also obtained research grants from the WA Cancer and Palliative Care Network (WACPN) and RPH Medical Research Fund (MRF) for research in co-operation with Cell and Tissue Therapies WA (CTTWA).
Dr Tan maintains an interest in the safe use of blood transfusion products and is a member of the RPH Blood Transfusion Committee. He is a member of the RPH Drug and Therapeutics Committee (DTC) that evaluates novel therapies. He supervises physician and haematology specialist trainees and lectures medical students at UWA. He is a haematopathologist at Western Diagnostics Pathology and is the current Chair of the Medical Advisory Committee (MAC) for Western Haematology & Oncology Clinics.
Dr Melita Cirillo
Dr Melita Cirillo is a specialist haematologist with a special interest in malignant haematology, particularly lymphoma, myeloma and leukaemia, and consultative haematology including obstetric haematology, bleeding and clotting disorders.
Dr Cirillo completed her medical training at the University of Western Australia and worked as a junior doctor at Royal Perth Hospital and King Edward Memorial Hospital, where she completed a Diploma in Obstetrics in 2011 (DRANZCOG). She later worked in Hawkes Bay (New Zealand) before returning to Perth to complete her training. She was awarded the AMAWA Junior Doctor of the Year in 2015 for her work in teaching and training for junior doctors.
Dr Cirillo currently works as a consultant haematologist at Royal Perth Hospital and Western Haematology and Oncology Clinics. She has an interest in translational clinical research and completed a fellowship in Cologne, Germany with the German Hodgkin Lymphoma Study Group. She is the lead investigator on several trials at Royal Perth Hospital, and brings her experience in the field of liquid biopsy to the research group at Perth Blood Institute. She is the recipient of research grants from WA Cancer Oncology Group, WA Health Research Registrar Program and Medical Research Foundation at Royal Perth Hospital. She maintains professional memberships with the Australian Leukaemia & Lymphoma Group (ALLG), Australasian Lymphoma Alliance (ALA) and Haematology Society of Australia and New Zealand (HSANZ).
Dr Cirillo believes that clear communication is one of the most important aspects in developing good relationships. She understands that blood conditions can be complex and many aspects of disease affect patient life. She aims to help provide clarity over therapeutic options and facilitate informed choices during the patient journey.
Dr Wei-Sen Lam
Dr Lam is a medical oncologist who treats a broad range of cancer with special interests in lung cancer and melanoma. Dr Lam graduated from the University of Western Australia and completed his specialist training at Fiona Stanley and Sir Charles Gairdner Hospital.
Wei-Sen has a keen interest in research and is actively involved in clinical trials. Dr Lam was a successful recipient of the WA Cancer and Palliative Care Network Fellowship and is a principal investigator in several lung cancer trials at Fiona Stanley Hospital. Dr Lam is actively involved in education as the co-chair for WA Clinical Oncology Group (WACOG).
He also has a Masters of Health Administration with Monash University and is currently the clinical lead for Medical Oncology and TeleOncology for the WA Country Health Service. He is passionate about improving cancer services for rural and remote WA and is known for his kind and approachable manner.
Dr Chandra Diwakarla
Dr Chandra Diwakarla is a Medical Oncologist based at Fiona Stanley and Royal Perth hospitals having recently moved to WA from Canberra.
Prior to commencing her medical degree, Dr Diwakarla completed a science degree with honours in viral genetics at the University of Melbourne where she focused on vaccine development. Following this her passion for patient centred care drove her to pursue a medical degree through Sydney University. Since then, Dr Diwakarla has completed her fellowship training in medical oncology and has gained extensive experience in both tertiary and rural environments across the ACT, NSW and WA. She is currently under taking her PhD studies investigating the role of novel therapies for the management of aggressive forms of breast cancer through the Australian National University.
Currently Dr Diwakarla works at both Royal Perth and Fiona Stanley hospitals where she has a particular interest in junior medical staff mentoring and teaching. She is the WA representative for the Young Oncology Group of Australia (YOGA) which is a subset of the Medical Oncology Group of Australia (MOGA) and has been involved in treatment protocol development along with various quality assurance programs across the country.
Dr Diwakarla is excited to be part of our new clinic and looks forward to establishing a supportive and caring environment where patient quality of life is the focus of care.
Dr Diwarkarla has a diverse range of experience in medical oncology with a sub-specialty interest in treating breast and gynaelogical cancers.